Researchers at Stanford University have developed a newly patented method for reducing the physiological symptoms of opioid withdrawal by targeting a well-characterized receptor.
Stanford researchers have developed a gene therapy that combines a retinal ganglion cell (RGC)- specific promoter with CRISPR gene editing to provide effective neuroprotection in optic neuropathies.
Stanford researchers have engineered an exceptionally bright, cyan-excitable orange-red fluorescent protein (CyOFP) that can be used both for multiplex imaging with GFP and for high-sensitivity, bioluminescent in vivo imaging.
We created a transgenic mouse on the FVB background in which the transgene is comprised of a strong constitutive promoter (CAG) driving expression of a dual reporter gene (luciferase and GFP). We called the original FVB mouse L2G85.
Researchers at Stanford have developed chimeric antigen receptors (CARs) that target glypican-2 (GPC2) and can be used to treat solid tumors. CAR-engineered T cells have shown great promise as cancer therapeutics.
Researchers at Stanford have developed a combination therapy to treat neuroblastoma, the most common and deadly solid tumor in childhood. Neuroblastoma derives from neural crest cells that fail to exit the cell cycle and differentiate.
Stanford researchers have developed and validated a quality assurance (QA) phantom that will facilitate the translation of a frameless volumetric modulated arc therapy radiosurgery technique.
Stanford researchers in Professor Rhiju Das's lab have devised a method called RNAMake to optimize nucleic acids, such as aptamers and messenger RNAs, and enhance their effectiveness for clinical settings.
This software tool takes clinical notes from veterinary electronic medical records and assigns SNOMED-CT VET extension diagnostic codes based on the content written on the notes.
Researchers in Prof. Yi Cui's laboratory have used a novel electrospinning process to fabricate a unique, transparent, highly conductive metal nanofiber material that could be used to replace indium tin oxide (ITO) in transparent electrodes.
Researchers in Prof. Steven Chu's laboratory have developed a fundamentally new method of acoustic imaging to improve resolution of ultrasound diagnostics.
Stanford researchers in the Dai Lab have developed the first ultra-bright cubic-phase erbium-based rare-earth nanoparticles (α-ErNPs) with down-shifting luminescence at ~ 1600 nm for in vivo NIR-IIb (1500-1700 nm) imaging with deep penetration and high clarity.